Crinetics Pharmaceuticals CRNX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's total current assets?
- Crinetics Pharmaceuticals (CRNX) reported total current assets of $1.32B in Q1 2026.
- How has Crinetics Pharmaceuticals's total current assets changed year-over-year?
- Crinetics Pharmaceuticals's total current assets increased by 2.4% year-over-year, from $1.29B to $1.32B.
- What is the long-term trend for Crinetics Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's total current assets has grown at a 42.6% compound annual growth rate (CAGR), from $177.49M to $1.05B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.